Articles

  • Oct 21, 2024 | blogs.bmj.com | James Kennedy

    In this blog the FG team would like to highlight our latest Open Access review on “Recent advances in the diagnosis and management of amoebiasis” by Cooney et al. This comprehensive but highly readable article will take you from wherever you are on the ‘zero to hero’ spectrum of amoebiasis to an overnight expert.

  • Sep 21, 2024 | thegamer.com | James Kennedy

    With so many games provided with UF0 50, it is hard to know where to start. This list will give you a sample of some of the best offerings.

  • Apr 11, 2024 | jdsupra.com | James Kennedy |Olivia King |F. Mark Reuter

    On April 5, 2024, a jury in Federal Court in California found that the SEC established that Defendant Matthew Panuwat was liable under a civil misappropriation theory of insider trading violations of Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. Panuwat formerly worked at a biopharmaceutical firm, Medivation, and bought call options in the biopharmaceutical firm Incyte minutes after learning that Medivation was to be acquired at a significant premium.

  • Apr 10, 2024 | kmklaw.com | James Kennedy |F. Mark Reuter |Allison Westfall |Olivia King

    On April 5, 2024, a jury in Federal Court in California found that the SEC established that Defendant Matthew Panuwat was liable under a civil misappropriation theory of insider trading violations of Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. Panuwat formerly worked at a biopharmaceutical firm, Medivation, and bought call options in the biopharmaceutical firm Incyte minutes after learning that Medivation was to be acquired at a significant premium.

  • Apr 5, 2024 | jdsupra.com | James Kennedy |Olivia King |F. Mark Reuter

    The U.S. Securities and Exchange Commission announced on April 4, 2024 that it is voluntarily delaying the implementation of its climate disclosure regulations while it fights an Eighth Circuit Court challenge seeking to vacate the rules.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →